
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 1058 | 1135 | 1305 | 1514 | 2691 |
Fund Return | 5.7% | 5.78% | 13.45% | 9.29% | 8.65% | 10.41% |
Place in category | 304 | 665 | 889 | 394 | 448 | 103 |
% in Category | 18 | 40 | 59 | 33 | 47 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Income Fund B Accumulation | 15.94M | 5.71 | 9.29 | 10.40 | ||
Income Fund Sterling Accumulation | 4.14M | 5.65 | 8.57 | 9.69 | ||
Income Fund Exempt 2 Income | 13.06M | 6.93 | 9.85 | 10.71 | ||
Income Fund Institutional W Accumul | 717.2M | 5.71 | 9.45 | 10.59 | ||
Income Fund Institutional W Income | 956.7M | 5.72 | 9.45 | 10.59 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 6.76B | 3.90 | 11.33 | 11.79 | ||
Income Fund B Accumulation | 15.94M | 5.71 | 9.29 | 10.40 | ||
Income Fund Exempt 2 Income | 13.06M | 6.93 | 9.85 | 10.71 | ||
Income Fund Institutional W Accumul | 717.2M | 5.71 | 9.45 | 10.59 | ||
Income Fund Institutional W Income | 956.7M | 5.72 | 9.45 | 10.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CME Group | US12572Q1058 | 3.45 | 254.57 | +0.21% | |
Cisco | US17275R1023 | 3.37 | 63.94 | +0.84% | |
Sanofi | FR0000120578 | 2.99 | 109.62 | 0.00% | |
Medtronic | IE00BTN1Y115 | 2.39 | 94.50 | +1.47% | |
Johnson Controls | IE00BY7QL619 | 2.22 | 80.06 | -1.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review